CAS: 41498-71-9; Rel-(1R,2R,4S)-Bicyclo[2.2.1]Heptan-2-Yl Formate

该化合物是来自诺本的双环酯,其特点是其外形配置和外形功能组,该化合物因其僵硬分子结构而显著,在合成应用中具有稳定性和回活动性;它是有机合成的多功能中间体,特别是在制作精细化学品,药品和特殊聚合物方面;其外观化学强化了循环和聚合反应中的选择性;该化合物在普通有机溶剂中表现出中等的波动性和溶解性,便于其在实验室和工业环境中的处理;其定义明确的结构对研究机械化学中的先质和电子影响很有价值.

结构式图片

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

formic acid norbornene norbornene norborn-2-eneexo-2-norbornanol

合成工艺路线路线简述

  • 合成目标产物 Exo-2-Norbornyl Formate 主要起始原料 Norbornene And Formic Acid
  • (文献来源)合成步骤主要原料 Norbornene 和 Formic Acid

海关参考信息

专利信息


专利号:US-6982344-B2
优先权日:2000-10-18
标 题:Process for preparation of optically active sulfonamides and intermediates for their synthesis
发明人:IKEMOTO TOMOMI; NISHIGUCHI ATSUKO; TOMIMATSU KIMINORI
权利人:TAKEDA PHARMACEUTICAL
摘要:A method including resolution of a diastereomeric mixture represented by the formula n n nwherein R 1 and R 2 are the same or different and each is an optionally substituted hydrocarbon group or an optionally substituted heterocyclic group, only one of R 1 and R 2 contains one asymmetric carbon, and R a is an optically active and optionally substituted hydrocarbon group or an optically active and optionally substituted heterocyclic group, or a salt thereof, to produce the diastereomer having a steric configuration of the asymmetric carbon for R 1 or R 2 of an R configuration or an S configuration, or a salt thereof.

专利号:US-2004049041-A1
优先权日:2000-10-18
标 题 :Process for preparation of optically active sulfonamides and intermediates for their synthesis

专利号:WO-9855085-A1
优先权日:1997-06-04
标题:Pharmaceutical compositions and methods
发明人:BROWN DAVID A; KHORLIN ALEXANDER A; LESIAK KRYSTYNA; REN WU YUN
权利人:CODON PHARMACEUTICALS INC; BROWN DAVID A; KHORLIN ALEXANDER A; LESIAK KRYSTYNA; REN WU YUN
摘要:Disclosed are methods and compositions for regulating the melanin content of mammalian melanocytes; regulating pigmentation in mammalian skin, hair, wool or fur; treating or preventing various skin and proliferative disorders; increasing the differentiation of mammalian neuronal cells for purposes of treating neurodegenerative diseases or nerve damage; and stimulating cellular nitric oxide (NO) synthesis, cyclic guanosine monophosphate levels (cGMP), and protein kinase G (PKG) activity for purposes of treating diseases mediated by deficiencies in the NO/cGMP/PKG signal transduction pathway; by administration of various compounds, including alcohols, diols and/or triols and their analogues.

专利号:EP-1334966-B1
优先权日:2000-10-18
标题:Process for preparation of optically active sulfonamides and intermediates for their synthesis

专利号:EP-1334966-A1
优先权日:2000-10-18
标 题 :Process for preparation of optically active sulfonamides and intermediates for their synthesis

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知